Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechSci Research | PRODUCT CODE: 1668045

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1668045

Organic Pharmaceutical Excipients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Function, By Application, By Region and Competition, 2020-2030F

PUBLISHED:
PAGES: 186 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4500
PDF and Excel (Multi-User License)
USD 5500
PDF and Excel (Custom Research License)
USD 8000

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

Global Organic Pharmaceutical Excipients Market was valued at USD 10.35 Billion in 2024 and is expected to reach USD 16.50 Billion in the forecast period with a CAGR of 8.06% through 2030. The Global Organic Pharmaceutical Excipients Market is a dynamic and rapidly evolving sector within the pharmaceutical industry, poised for substantial growth in the coming years. Pharmaceutical excipients are inactive substances that are added to drug formulations to enhance their stability, bioavailability, and overall performance. Organic pharmaceutical excipients, derived from natural sources, have gained significant attention due to the increasing demand for organic and clean-label pharmaceutical products.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 10.35 Billion
Market Size 2030USD 16.50 Billion
CAGR 2025-20308.06%
Fastest Growing SegmentOral Formulations
Largest MarketNorth America

One of the key drivers of this market's growth is the rising consumer awareness and preference for organic and natural ingredients in pharmaceuticals. As individuals become more health-conscious and concerned about the potential side effects of synthetic additives, there has been a notable shift towards organic excipients. This trend aligns with the broader movement towards clean and sustainable healthcare solutions, driving the demand for organic pharmaceutical excipients.

Additionally, regulatory bodies across the globe have been advocating for the use of safer and more environmentally friendly excipients, further propelling the market for organic alternatives. These excipients, often sourced from plant-based materials such as cellulose, starch, and gums, offer a sustainable and eco-friendly option for pharmaceutical formulation.

Furthermore, the pharmaceutical industry's ongoing research and development efforts, coupled with advancements in biotechnology and nanotechnology, have created opportunities for innovative organic excipient formulations. These innovations aim to address specific challenges in drug delivery, solubility, and bioavailability, opening doors for organic excipients to play a crucial role in the development of novel drug formulations.

Key Market Drivers

Increasing Consumer Preference for Organic Products

The increasing consumer preference for organic products is a significant driving force behind the growing global organic pharmaceutical excipients market. In recent years, there has been a discernible shift in consumer attitudes towards health and wellness, leading to a heightened demand for organic and natural alternatives in various aspects of life, including pharmaceuticals.

Consumers today are more health-conscious and discerning than ever before. They are increasingly concerned about the potential side effects and health risks associated with synthetic ingredients and additives in pharmaceutical products. This heightened awareness has led to a growing preference for clean-label medications formulated with organic pharmaceutical excipients. These organic excipients, often sourced from natural materials like cellulose, starch, and gums, are considered safer and more aligned with the principles of holistic health and well-being.

The desire for transparency and clean ingredients in pharmaceuticals has become a central factor in consumer choices. Organic excipients offer the assurance of a natural and sustainable approach to medication, which resonates with consumers seeking healthier alternatives. Furthermore, organic pharmaceutical excipients are generally free from allergens and contaminants, which makes them a safer choice for individuals with sensitivities or allergies. Regulatory bodies have also recognized the importance of organic excipients in pharmaceutical formulations, aligning their guidelines and recommendations with consumer preferences. This convergence of consumer demand and regulatory support has created a conducive environment for the growth of the global organic pharmaceutical excipients market..

In response to the increasing prevalence of GERD, the Global Organic Pharmaceutical Excipients Market has expanded to provide innovative and advanced diagnostic tools. These tools include pH monitoring systems, impedance-pH monitoring systems, and other cutting-edge devices designed to precisely assess and diagnose GERD. Additionally, the market has seen the development of patient-friendly, minimally invasive testing options, which encourage individuals to seek diagnosis and treatment.

Key Market Challenges

Limited Availability and Variability of Organic Raw Materials

The global organic pharmaceutical excipients market is experiencing robust growth, driven by the rising demand for natural and sustainable pharmaceutical products. Organic excipients, sourced from natural materials like plants and starches, are gaining popularity for their clean-label appeal and eco-friendly attributes. However, one of the key challenges hindering the growth of this market is the limited availability and variability of organic raw materials.

Organic excipients are primarily derived from natural sources, and their quality and availability are influenced by various factors, including climate, soil conditions, and agricultural practices. Unlike synthetic excipients, which can be manufactured with a high degree of precision and consistency, organic raw materials are subject to the vagaries of nature. This inherent variability can pose several challenges for the pharmaceutical industry.

The limited availability of organic raw materials can lead to supply chain disruptions. The production of organic excipients relies on a steady and sustainable supply of organic feedstock. When these raw materials are in short supply due to factors such as adverse weather conditions or fluctuations in crop yields, pharmaceutical manufacturers may face delays in production or increased costs as they seek alternative sources.

the variability in the quality and composition of organic raw materials can impact the consistency of organic excipients. Pharmaceutical formulations require precise and predictable properties to ensure the safety and efficacy of medications. Variability in excipient characteristics can make it challenging to achieve the desired drug formulation attributes, leading to concerns about product performance and patient safety.

Moreover, the variability of organic raw materials can also affect the cost of production. Pharmaceutical companies may need to invest in rigorous quality control processes to mitigate the impact of variations in organic excipients. This additional quality control can lead to increased production costs, potentially making organic excipients less competitive compared to their synthetic counterparts.

Key Market Trends

Rising Consumer Demand for Clean-Label Pharmaceuticals

The rising consumer demand for clean-label pharmaceuticals is a pivotal driver behind the burgeoning global organic pharmaceutical excipients market. In recent years, consumers have become increasingly health-conscious and discerning about the products they consume, including medications. This shift in consumer preferences towards clean-label pharmaceuticals, which are characterized by transparent ingredient lists containing natural and organic components, has created a substantial surge in demand for organic excipients.

Consumers are now more than ever concerned about the safety and efficacy of the medications they take, as well as the potential side effects of synthetic additives and artificial ingredients. They are actively seeking pharmaceutical products that align with their preference for natural and sustainable ingredients, and organic excipients fit the bill perfectly.

Organic excipients, sourced from natural materials like plant-based cellulose, starch, and gums, offer consumers a sense of transparency and assurance in their pharmaceuticals. These excipients are perceived as safer, cleaner, and more environmentally friendly than their synthetic counterparts. They resonate with consumers' desires for holistic health and well-being and cater to their demand for clean-label products free from synthetic and artificial additives.

The clean-label movement extends beyond the food and beverage industry, where it originated, and has made its way into pharmaceuticals. Consumers now prioritize pharmaceutical products that contain recognizable and natural ingredients, which has placed organic excipients in the spotlight.

Additionally, regulatory bodies have taken note of this consumer trend, encouraging pharmaceutical manufacturers to opt for safer and more environmentally friendly excipients in their formulations. The regulatory support for clean-label pharmaceuticals, which often includes organic excipients, further propels their market growth.

Key Market Players

  • Roquette Freres SA
  • DuPont de Nemours Inc.
  • Ashland Inc.
  • BASF SE
  • Kerry Group plc
  • Evonik Industries AG
  • Croda International plc
  • The Lubrizol Corporation
  • Innophos Holdings Inc.
  • Wacker Chemie AG

Report Scope:

In this report, the Global Organic Pharmaceutical Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organic Pharmaceutical Excipients Market, By Type:

  • Oleochemicals
  • Carbohydrates
  • Petrochemicals
  • Protein
  • Other

Organic Pharmaceutical Excipients Market, By Function:

  • Binders
  • Coating Agents
  • Colorants
  • Disintegrates
  • Other Functions

Organic Pharmaceutical Excipients Market, By Application:

  • Oral Formulations
  • Topical Formulations
  • Parenteral Formulations
  • Other Applications

Organic Pharmaceutical Excipients Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organic Pharmaceutical Excipients Market.

Available Customizations:

Global Organic Pharmaceutical Excipients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Product Code: 18970

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Organic Pharmaceutical Excipients Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type (Oleochemicals, Carbohydrates, Petrochemicals; Protein, Other)
    • 4.2.2. By Function (Binders, Coating Agents, Colorants, Disintegrates, Other Functions)
    • 4.2.3. By Application (Oral Formulations, Topical Formulations, Parenteral Formulations, Other Applications)
    • 4.2.4. By Region
    • 4.2.5. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Type
    • 4.3.2. By Function
    • 4.3.3. By Application
    • 4.3.4. By Region

5. Asia Pacific Organic Pharmaceutical Excipients Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Function
    • 5.2.3. By Application
    • 5.2.4. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Organic Pharmaceutical Excipients Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Type
        • 5.3.1.2.2. By Function
        • 5.3.1.2.3. By Application
    • 5.3.2. India Organic Pharmaceutical Excipients Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Type
        • 5.3.2.2.2. By Function
        • 5.3.2.2.3. By Application
    • 5.3.3. Australia Organic Pharmaceutical Excipients Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Type
        • 5.3.3.2.2. By Function
        • 5.3.3.2.3. By Application
    • 5.3.4. Japan Organic Pharmaceutical Excipients Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Type
        • 5.3.4.2.2. By Function
        • 5.3.4.2.3. By Application
    • 5.3.5. South Korea Organic Pharmaceutical Excipients Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Type
        • 5.3.5.2.2. By Function
        • 5.3.5.2.3. By Application

6. Europe Organic Pharmaceutical Excipients Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Function
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Organic Pharmaceutical Excipients Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Function
        • 6.3.1.2.3. By Application
    • 6.3.2. Germany Organic Pharmaceutical Excipients Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Function
        • 6.3.2.2.3. By Application
    • 6.3.3. Spain Organic Pharmaceutical Excipients Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Function
        • 6.3.3.2.3. By Application
    • 6.3.4. Italy Organic Pharmaceutical Excipients Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Function
        • 6.3.4.2.3. By Application
    • 6.3.5. United Kingdom Organic Pharmaceutical Excipients Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Function
        • 6.3.5.2.3. By Application

7. North America Organic Pharmaceutical Excipients Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Function
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Organic Pharmaceutical Excipients Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Function
        • 7.3.1.2.3. By Application
    • 7.3.2. Mexico Organic Pharmaceutical Excipients Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Function
        • 7.3.2.2.3. By Application
    • 7.3.3. Canada Organic Pharmaceutical Excipients Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Function
        • 7.3.3.2.3. By Application

8. South America Organic Pharmaceutical Excipients Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Function
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Organic Pharmaceutical Excipients Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Function
        • 8.3.1.2.3. By Application
    • 8.3.2. Argentina Organic Pharmaceutical Excipients Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Function
        • 8.3.2.2.3. By Application
    • 8.3.3. Colombia Organic Pharmaceutical Excipients Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Function
        • 8.3.3.2.3. By Application

9. Middle East and Africa Organic Pharmaceutical Excipients Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Function
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Organic Pharmaceutical Excipients Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Function
        • 9.3.1.2.3. By Application
    • 9.3.2. Saudi Arabia Organic Pharmaceutical Excipients Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Function
        • 9.3.2.2.3. By Application
    • 9.3.3. UAE Organic Pharmaceutical Excipients Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Function
        • 9.3.3.2.3. By Application

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Organic Pharmaceutical Excipients Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Roquette Freres SA
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Current Capacity Analysis
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. DuPont de Nemours Inc.
  • 14.3. Ashland Inc.
  • 14.4. BASF SE
  • 14.5. Kerry Group plc
  • 14.6. Evonik Industries AG
  • 14.7. Croda International plc
  • 14.8. The Lubrizol Corporation
  • 14.9. Innophos Holdings Inc.
  • 14.10. Wacker Chemie AG

15. Strategic Recommendations

16. About Us & Disclaimer

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!